BNP Paribas Financial Markets’s Agilon Health AGL Stock Holding History

BNP Paribas Financial Markets’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.18M	Sell	11,055 -14,725	-57%	-$964K	﹤0.01%	3203
2026 Q1	$204K	Buy	25,780 +21,546	+509%	+$348K	﹤0.01%	4040
2025 Q4	$72.9K	Sell	4,234 -50,891	-92%	-$987K	﹤0.01%	4515
2025 Q3	$1.42M	Buy	55,125 +53,531	+3,358%	+$2.02M	﹤0.01%	2873
2025 Q2	$91.7K	Sell	1,594 -389	-20%	-$31.2K	﹤0.01%	4052
2025 Q1	$215K	Sell	1,983 -11,829	-86%	-$1.03M	﹤0.01%	3650
2024 Q4	$656K	Buy	+13,812	New	+$835K	﹤0.01%	3102
2022 Q4	–	Sell	-847	Closed	-$496K	–	4045
2022 Q3	$496K	Buy	+847	New	+$507K	﹤0.01%	2985

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BNP Paribas Financial Markets's AGL Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Agilon Health (AGL) stake by 57% in Q2 2026, selling an estimated $964K and leaving 11,055 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #3203.

BNP Paribas Financial Markets first reported a position in AGL in Q3 2022 and has held it in 8 quarters since. The position peaked at $1.42M in Q3 2025. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

BNP Paribas Financial Markets held 11,055 shares of Agilon Health worth $1.18M as of Q2 2026.
BNP Paribas Financial Markets sold 14,725 Agilon Health shares in Q2 2026, an estimated $964K.
Agilon Health made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3203 holding.
BNP Paribas Financial Markets first reported a position in Agilon Health in Q3 2022 and has held it in 8 quarters since.
BNP Paribas Financial Markets's Agilon Health position peaked at $1.42M in Q3 2025.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.